Search Results - "Maceyko, R F"

Oral and cutaneous lichen planus pemphigoides by Maceyko, R F, Camisa, C, Bergfeld, W F, Valenzuela, R

“…Lichen planus pemphigoides is a rare bullous disorder characterized by tense bullae on lichen planus lesions and on clinically uninvolved skin. A diagnosis of…”
Get more information

Vasopressin-associated cutaneous infarcts, alopecia, and neuropathy by Maceyko, R F, Vidimos, A T, Steck, W D

Get more information

Kasabach-Merritt syndrome by Maceyko, R F, Camisa, C

“…The Kasabach-Merritt syndrome includes the triad of vascular tumors, thrombocytopenia, and a hemorrhagic diathesis. The vascular tumors are usually benign but…”
Get more information

Treatment of psoriasis with long-term administration of somatostatin analog 201-995 by Camisa, C, Maceyko, R F, O'Dorisio, T M, Schacht, G E, Mekhjian, H S

Get more information

Mucocutaneous presentations of Crohn's disease by Glanz, S, Maceyko, R F, Camisa, C, Tomecki, K J

“…Crohn's disease is an idiopathic inflammatory process that predominantly affects the gastrointestinal tract. Numerous extraintestinal manifestations of Crohn's…”
Get more information

Treatment of psoriasis with chronic subcutaneous administration of somatostatin analog 201-995 (sandostatin). I. An open-label pilot study by Camisa, C, O'Dorisio, T M, Maceyko, R F, Schacht, G E, Mekhjian, H S, Howe, B A

“…Increased levels of human growth hormone (HGH) may correlate with the severity of psoriasis and native somatostatin (SRIF) may improve it by inhibiting HGH…”
Get more information

Treatment of psoriasis with chronic subcutaneous administration of somatostatin analog 201-995 (sandostatin). II. Effect on pancreatic and thyroid hormone by Camisa, C, Schacht, G E, O'Dorisio, T M, Maceyko, R F

“…Nine patients with psoriasis vulgaris were treated for 12 weeks with somatostatin analog, octreotide acetate (SMS 201-995) 50 or 100 micrograms by subcutaneous…”
Get more information